Related references
Note: Only part of the references are listed.Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption
Mauricio dos-Santos-Pereira et al.
GLIA (2020)
Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes
Viviana di Giacomo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Peripheral and cerebral abnormalities of the tryptophan metabolism in the depression-like rats induced by chronic unpredicted mild stress
Chen-Chen Li et al.
NEUROCHEMISTRY INTERNATIONAL (2020)
Targeting β-Catenin in GLAST-Expressing Cells: Impact on Anxiety and Depression-Related Behavior and Hippocampal Proliferation
Rebeca Vidal et al.
MOLECULAR NEUROBIOLOGY (2019)
Common mental disorders within chronic inflammatory disorders: a primary care database prospective investigation
Alexandru Dregan et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
miRNA expression profiles and molecular networks in resting and LPS-activated BV-2 microglia-Effect of cannabinoids
Ana Juknat et al.
PLOS ONE (2019)
The Yin' and the Yang' of the kynurenine pathway: excitotoxicity and neuroprotection imbalance in stress-induced disorders
Pascal Barone
BEHAVIOURAL PHARMACOLOGY (2019)
Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue
Daniela Enache et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Microglial production of quinolinic acid as a target and a biomarker of the antidepressant effect of ketamine
Franck Verdonk et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms
Gabriela Pandini Silote et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2019)
S 47445 counteracts the behavioral manifestations and hippocampal neuroplasticity changes in bulbectomized mice
Fuencisla Pilar-Cuellar et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors
Andreza B. Sonego et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Major depression model induced by repeated and intermittent lipopolysaccharide administration: Long-lasting behavioral, neuroimmune and neuroprogressive alterations
Francisca Taciana Sousa Rodrigues et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
LPS-stimulated NF-kappa B p65 dynamic response marks the initiation of TNF expression and transition to IL-10 expression in RAW 264.7 macrophages
Stuart Hobbs et al.
PHYSIOLOGICAL REPORTS (2018)
Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis
Sabrina Giacoppo et al.
FITOTERAPIA (2017)
Selective increase of cerebrospinal fluid IL-6 during experimental systemic inflammation in humans: association with depressive symptoms
H. Engler et al.
MOLECULAR PSYCHIATRY (2017)
Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health
Igor Cervenka et al.
SCIENCE (2017)
Enhanced Stress Response in 5-HT1AR Overexpressing Mice: Altered HPA Function and Hippocampal Long-Term Potentiation
Fuencisla Pilar-Cuellar et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Anti-inflammatory mechanism of galangin in lipopolysaccharide-stimulated microglia: Critical role of PPAR-γ signaling pathway
Min-Ji Choi et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Upregulation of neuronal kynurenine 3-monooxygenase mediates depression-like behavior in a mouse model of neuropathic pain
Geoffroy Laumet et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
How do antidepressants work? New perspectives for refining future treatment approaches
Catherine J. Harmer et al.
LANCET PSYCHIATRY (2017)
Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration
A. Ferres-Coy et al.
MOLECULAR PSYCHIATRY (2016)
Men and women differ in inflammatory and neuroendocrine responses to endotoxin but not in the severity of sickness symptoms
Harald Engler et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
An update on PPAR activation by cannabinoids
Saoirse Elizabeth O'Sullivan
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
Raquel Linge et al.
NEUROPHARMACOLOGY (2016)
Prohedonic Effect of Cannabidiol in a Rat Model of Depression
Gal Shoval et al.
NEUROPSYCHOBIOLOGY (2016)
Neurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation
J. M. Parrott et al.
TRANSLATIONAL PSYCHIATRY (2016)
Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder
Rita Haapakoski et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Cannabidiol as a Potential Treatment for Anxiety Disorders
Esther M. Blessing et al.
NEUROTHERAPEUTICS (2015)
Peripheral Administration of Tumor Necrosis Factor-Alpha Induces Neuroinflammation and Sickness but Not Depressive-Like Behavior in Mice
Steven Biesmans et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Effects of voluntary wheel running on LPS-induced sickness behavior in aged mice
Stephen A. Martin et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Serotonin - Kynurenine Hypothesis of Depression: Historical Overview and Recent Developments
Gregory Oxenkrug
CURRENT DRUG TARGETS (2013)
Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation
Karina S. MacDowell et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
Alline C. Campos et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors
Marcus A. Lawson et al.
JOURNAL OF NEUROINFLAMMATION (2013)
NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice
Adam K. Walker et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid-Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells
Ana Juknat et al.
PLOS ONE (2013)
Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration
Yuta Ohgi et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways
Michael Maes et al.
BMC MEDICINE (2012)
Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability
A. Alhamoruni et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Ligand-dependent nucleo-cytoplasmic shuttling of peroxisome proliferator-activated receptors, PPARα and PPARγ
Tomoe Umemoto et al.
GENES TO CELLS (2012)
Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge
Alexander Salazar et al.
HORMONES AND BEHAVIOR (2012)
The Role of Indoleamine 2,3-Dioxygenase in a Mouse Model of Neuroinflammation-Induced Depression
Nikoletta Dobos et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression
Brian Leonard et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2012)
PPARγ is an E3 ligase that induces the degradation of NFκB/p65
Yongzhong Hou et al.
NATURE COMMUNICATIONS (2012)
Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes
S. J. Sukoff Rizzo et al.
TRANSLATIONAL PSYCHIATRY (2012)
Cannabidiol Reduces Ab- Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
Giuseppe Esposito et al.
PLOS ONE (2011)
The new '5-HT' hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
M. Maes et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
A Meta-Analysis of Cytokines in Major Depression
Yekta Dowlati et al.
BIOLOGICAL PSYCHIATRY (2010)
Corticosterone basal levels and vulnerability to LPS-induced neuroinflammation in the rat brain
Beatriz G. Perez-Nievas et al.
BRAIN RESEARCH (2010)
Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
T. V. Zanelati et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation
I. Magen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
Abir T. El-Alfy et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Nuclear factor-κB is a critical mediator of stress-impaired neurogenesis and depressive behavior
Ja Wook Koo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Time-dependent vascular actions of cannabidiol in the rat aorta
Saoirse E. O'Sullivan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Δ9-Tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro
Marcel Jenny et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatment
S. J. Bull et al.
MOLECULAR PSYCHIATRY (2009)
Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
J. C. O'Connor et al.
MOLECULAR PSYCHIATRY (2009)
Human Endotoxemia as a model of systemic inflammation
A. S. Andreasen et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration
Caroline Andre et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
From inflammation to sickness and depression: when the immune system subjugates the brain
Robert Dantzer et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge:: A role for IFN-γ?
Thomas J. Connor et al.
NEUROSCIENCE LETTERS (2008)
Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system
Jonathan P. Godbout et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Immunity and emotions: Lipopolysaccharide increases defensive behaviours and potentiates despair in mice
Julien Renault et al.
BRAIN BEHAVIOR AND IMMUNITY (2006)
IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors
Sabine Chourbaji et al.
NEUROBIOLOGY OF DISEASE (2006)
Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in β-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-κB involvement
Giuseppe Esposito et al.
NEUROSCIENCE LETTERS (2006)
Achieving stability of lipopolysaccharide-induced NF-κB activation
MW Covert et al.
SCIENCE (2005)
Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats
B García-Bueno et al.
BIOLOGICAL PSYCHIATRY (2005)
Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA
D Kelly et al.
NATURE IMMUNOLOGY (2004)
Activation of peroxisome proliferator-activated receptor-γ inhibits differentiation of preosteoblasts
E Khan et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2003)
Cannabidiol: An overview of some pharmacological aspects
R Mechoulam et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes
T Kawai et al.
JOURNAL OF IMMUNOLOGY (2001)
Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-γ and nuclear factor-κB
SW Chung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
